The store will not work correctly when cookies are disabled.
ID: ALA3116031
Max Phase: Preclinical
Molecular Formula: C16H15Cl2N5
Molecular Weight: 348.24
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Clc1ccc2c(NCCCNc3nccc(Cl)n3)ccnc2c1
Standard InChI: InChI=1S/C16H15Cl2N5/c17-11-2-3-12-13(4-8-20-14(12)10-11)19-6-1-7-21-16-22-9-5-15(18)23-16/h2-5,8-10H,1,6-7H2,(H,19,20)(H,21,22,23)
Standard InChI Key: KNYVQHOAQKLRGM-UHFFFAOYSA-N
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Properties
Molecular Weight: 348.24 | Molecular Weight (Monoisotopic): 347.0705 | AlogP: 4.25 | #Rotatable Bonds: 6 |
Polar Surface Area: 62.73 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 7.31 | CX LogP: 3.12 | CX LogD: 2.88 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.52 | Np Likeness Score: -1.35 |
References
1. Singh K, Kaur H, Smith P, de Kock C, Chibale K, Balzarini J.. (2014) Quinoline-pyrimidine hybrids: synthesis, antiplasmodial activity, SAR, and mode of action studies., 57 (2): [PMID:24354322] [10.1021/jm4014778] |
2. Singh K, Kaur T. (2016) Pyrimidine-based antimalarials: design strategies and antiplasmodial effects, 7 (5): [10.1039/C6MD00084C] |